Condensed Consolidating Financial Information - Cash Flows (Details) - USD ($) $ in Thousands | 6 Months Ended |
Jun. 30, 2016 | Jun. 30, 2015 |
Condensed Consolidating Statements Of Cash Flows | | |
Net cash provided by (used for) operating activities | $ 336,672 | $ 517,404 |
Cash flows from investing activities: | | |
Purchases of investments | | 8 |
Sales and maturities of investments | 367 | 745 |
Capital expenditures | (193,234) | (566,672) |
Proceeds from sales of assets and insurance claims | 13,834 | 24,790 |
Other | 38 | 1,809 |
Cash paid for acquisition of businesses, net | | (57,909) |
Investment in unconsolidated affiliates | | (445) |
Proceeds from merger transaction | | 660,050 |
Net cash (used for) provided by investing activities | (178,995) | 62,360 |
Cash flows from financing activities: | | |
Increase (decrease) in cash overdrafts | 294 | 310 |
Proceeds from (payments for) issuance of common shares | 39 | 1,198 |
Reduction in revolving credit facilities | (260,000) | (450,000) |
Repurchase of common shares | (1,687) | |
Reduction of long-term debt | (148,045) | |
Dividends to shareholders | (16,922) | (34,980) |
Proceeds from (payments for) commercial paper, net | (1,500) | (208,467) |
Proceeds from revolving credit facilities | 260,000 | |
Proceeds from term Loan | | 300,000 |
Payments on term loan facility | | (300,000) |
Payments on term loan | | (300,000) |
Repurchase of common shares | (1,687) | |
Dividends to shareholders | 16,922 | 34,980 |
Proceeds from short-term borrowings | (6,333) | 60,169 |
Other | (4,280) | (7,426) |
Net cash (used for) provided by financing activities | (178,434) | (639,196) |
Effect of exchange rate changes on cash and cash equivalents | (21) | (5,042) |
Net increase (decrease) in cash and cash equivalents | (20,778) | (64,474) |
Cash and cash equivalents, beginning of period | 254,530 | 501,149 |
Cash and cash equivalents, end of period | 233,752 | 436,675 |
Reportable Legal Entities | Parent Company | | |
Condensed Consolidating Statements Of Cash Flows | | |
Net cash provided by (used for) operating activities | 4,370 | 40,628 |
Cash flows from investing activities: | | |
Proceeds from merger transaction | | 5,500 |
Net cash (used for) provided by investing activities | | 5,500 |
Cash flows from financing activities: | | |
Proceeds from (payments for) issuance of common shares | 39 | 1,198 |
Dividends to shareholders | (19,903) | (39,634) |
Proceeds from issuance of intercompany debt | 24,500 | 27,000 |
Dividends to shareholders | 19,903 | 39,634 |
Paydown of intercompany debt | | (27,000) |
Other | (4,281) | (7,426) |
Net cash (used for) provided by financing activities | 355 | (45,862) |
Net increase (decrease) in cash and cash equivalents | 4,725 | 266 |
Cash and cash equivalents, beginning of period | 873 | 1,170 |
Cash and cash equivalents, end of period | 5,598 | 1,436 |
Reportable Legal Entities | Guarantor Subsidiaries | | |
Condensed Consolidating Statements Of Cash Flows | | |
Net cash provided by (used for) operating activities | (134,437) | (120,729) |
Cash flows from investing activities: | | |
Change in intercompany balances | 135,938 | 45,063 |
Proceeds from merger transaction | | 646,078 |
Net cash (used for) provided by investing activities | 135,938 | 691,141 |
Cash flows from financing activities: | | |
Reduction in revolving credit facilities | (260,000) | (450,000) |
Proceeds from (payments for) commercial paper, net | (1,500) | (208,467) |
Proceeds from issuance of intercompany debt | | 88,058 |
Proceeds from revolving credit facilities | 260,000 | |
Proceeds from term Loan | | 300,000 |
Payments on term loan facility | | (300,000) |
Payments on term loan | | (300,000) |
Net cash (used for) provided by financing activities | (1,500) | (570,409) |
Net increase (decrease) in cash and cash equivalents | 1 | 3 |
Cash and cash equivalents, beginning of period | 10 | 7 |
Cash and cash equivalents, end of period | 11 | 10 |
Reportable Legal Entities | Other Subsidiaries (Non-Guarantors) | | |
Condensed Consolidating Statements Of Cash Flows | | |
Net cash provided by (used for) operating activities | 469,720 | 623,481 |
Cash flows from investing activities: | | |
Purchases of investments | | 8 |
Sales and maturities of investments | 367 | 745 |
Capital expenditures | (193,234) | (566,672) |
Proceeds from sales of assets and insurance claims | 13,834 | 24,790 |
Change in intercompany balances | (135,938) | (45,063) |
Other | 38 | 1,809 |
Cash paid for acquisition of businesses, net | | (57,909) |
Investment in unconsolidated affiliates | | (445) |
Proceeds from merger transaction | | 8,472 |
Net cash (used for) provided by investing activities | (314,933) | (634,281) |
Cash flows from financing activities: | | |
Increase (decrease) in cash overdrafts | 294 | 310 |
Repurchase of common shares | (1,687) | |
Reduction of long-term debt | (148,045) | |
Proceeds from issuance of intercompany debt | (24,500) | (115,058) |
Repurchase of common shares | (1,687) | |
Proceeds from short-term borrowings | (6,333) | 60,169 |
Paydown of intercompany debt | | 27,000 |
Payments on parent (Equity or N/P) | | (21,322) |
Other | 1 | |
Net cash (used for) provided by financing activities | (180,270) | (48,901) |
Effect of exchange rate changes on cash and cash equivalents | (21) | (5,042) |
Net increase (decrease) in cash and cash equivalents | (25,504) | (64,743) |
Cash and cash equivalents, beginning of period | 253,647 | 499,972 |
Cash and cash equivalents, end of period | 228,143 | 435,229 |
Consolidating Adjustments | | |
Condensed Consolidating Statements Of Cash Flows | | |
Net cash provided by (used for) operating activities | (2,981) | (25,976) |
Cash flows from financing activities: | | |
Dividends to shareholders | 2,981 | 4,654 |
Dividends to shareholders | (2,981) | (4,654) |
Payments on parent (Equity or N/P) | | 21,322 |
Net cash (used for) provided by financing activities | $ 2,981 | $ 25,976 |